Stock fell 18% on weak Q2 guidance showing sharp deceleration in revenue growth from 17% to 3-8% YOY. Company faces multiple headwinds including macroeconomic pressures (elevated oil prices, geopolitical volatility), regulatory investigation by China's State Administration for Market Regulation, and operational compliance costs. Stock down 49% from 52-week high and market cap halved from $50B to $26B.
Partnership with HKTB to distribute HK$20 million in travel deals and attraction packages, positioning the platform as a key booking channel for Hong Kong summer travel and expanding its market reach in the region.
The company is the subject of a securities fraud class action lawsuit alleging material misstatements and failure to disclose regulatory risks related to monopolistic business practices, which directly harms investor interests and indicates serious corporate governance and compliance issues.
The company is the subject of a securities class action lawsuit alleging material misstatements and failure to disclose regulatory risks related to monopolistic business activities. Investors claim they suffered damages when the true details entered the market.
Company is under antitrust investigation by Chinese regulators for alleged monopolistic practices and market abuse. Stock experienced significant decline of 17.05% on announcement, and a securities class action lawsuit has been filed against the company and its executives for failing to disclose material information.
Company is subject to antitrust investigation by Chinese regulators for alleged monopolistic practices and market abuse. Stock declined 19.4% on the news, and the company faces securities fraud litigation for failing to disclose material information about the regulatory probe.
The company faces a class action lawsuit for alleged securities fraud and unlawful business practices, coupled with a Chinese antitrust investigation for monopolistic conduct. The stock experienced a significant 17.05% price decline following the antitrust probe announcement, indicating serious legal and regulatory risks.
The company faces a class action lawsuit alleging false statements about regulatory risks and undisclosed antitrust vulnerabilities. A Chinese government antitrust investigation was announced, resulting in a 19% stock price decline, indicating significant legal and regulatory headwinds.
The company faces a securities fraud class action lawsuit based on allegations of making materially false statements and failing to disclose antitrust investigations by Chinese regulators. The revelation of these investigations caused a significant 17.05% stock price decline, indicating serious legal and regulatory risks to investors.
The company is the subject of a securities class action lawsuit alleging material misstatements and omissions regarding regulatory risks from monopolistic business practices. Investors who purchased securities during the class period may have suffered damages.
The company is the subject of a securities class action lawsuit alleging material misstatements and omissions regarding regulatory risks from monopolistic business practices. Investors who purchased during the class period may have suffered damages, indicating serious corporate governance and disclosure concerns.
Trip.com faces a class action lawsuit alleging material misstatements regarding regulatory risks, coupled with a 17.05% stock price decline following a Chinese government anti-monopoly investigation announcement. These developments indicate significant legal and regulatory challenges that negatively impact investor confidence and shareholder value.
The company is the subject of a securities class action lawsuit alleging material misrepresentation of regulatory risks. A 17% stock price decline occurred following disclosure of a Chinese anti-monopoly investigation. Co-founders resigned abruptly, and the company subsequently shut down its controversial AI pricing tool, indicating serious governance and operational issues.
Company faces a major securities lawsuit alleging material misrepresentation of regulatory risks related to its AI pricing tool. The stock declined 17% following the anti-monopoly investigation announcement, wiping out $8 billion in market capitalization. Co-founders resigned and the controversial AI tool was shut down, indicating serious governance and operational issues.
Company faces securities class action lawsuit, 17% stock decline, $8 billion market cap loss, anti-monopoly investigation by Chinese regulators, allegations of misleading investors about AI pricing tool risks, forced shutdown of the tool, and abrupt resignation of co-founders from the board.
Company is defendant in securities class action lawsuit alleging false and misleading statements about regulatory risks related to monopolistic business activities, resulting in investor damages.
The company is the subject of a securities class action lawsuit alleging material misstatements and omissions regarding regulatory risks from monopolistic business practices. Investors who purchased securities during the class period may have suffered damages, indicating significant legal and reputational risk to the company.
Company is defendant in securities class action lawsuit alleging false/misleading statements regarding regulatory risks from monopolistic business activities, resulting in investor losses during the Class Period (April 30, 2024 - January 13, 2026).
The company is the subject of a securities class action lawsuit alleging material misstatements and omissions regarding regulatory risks from monopolistic business practices, resulting in investor losses.
Company faces antitrust investigation by Chinese regulators for alleged monopolistic practices and market abuse. Defendants are accused of understating regulatory risks and making materially false statements about business operations. Stock experienced significant price declines (17.05% and 2.35%) following disclosure of the investigation.
The company is the subject of a securities class action lawsuit alleging material misrepresentation of regulatory risks. A 17% stock price decline occurred following disclosure of a Chinese regulatory investigation. The company's AI pricing tool was identified as enabling monopolistic conduct and was subsequently shut down, indicating serious business model and compliance issues.
Company is defendant in securities class action lawsuit alleging false/misleading statements about regulatory risks related to monopolistic business activities and material misrepresentations about business operations and prospects.
The company faces a securities fraud class action lawsuit alleging material misstatements about monopolistic business activities and regulatory risks. Additionally, China's antitrust investigation and accusations of abusing market position resulted in a 17.05% stock price decline, indicating significant legal and regulatory headwinds.
Company faces significant regulatory investigation in China for alleged monopolistic practices, 17% stock decline wiping out $8 billion in market cap, securities class action lawsuit, co-founder resignations, and forced shutdown of its core AI pricing tool. Multiple allegations of investor deception regarding business model sustainability and regulatory risks.
Company is defendant in securities class action lawsuit alleging false and misleading statements about business operations and understated regulatory risks related to monopolistic business activities.
The company is the subject of a securities fraud lawsuit alleging false and misleading statements regarding regulatory risks and monopolistic business practices, resulting in investor losses.
Company faces securities fraud allegations for understating regulatory risks related to monopolistic activities. Stock declined 17.1% following disclosure of a Chinese anti-monopoly investigation, indicating significant investor losses and legal liability.
Company faces securities class action lawsuit for allegedly making false statements about regulatory risks. China initiated an antitrust probe into Trip.com's monopolistic business activities, resulting in a 19% stock price decline over two trading sessions.
The company faces a securities fraud class action lawsuit alleging material misstatements about monopolistic business activities and regulatory risks. China's antitrust investigation and accusations of abusing market position triggered a 17.05% stock price decline, indicating significant legal and regulatory headwinds.
The company faces allegations of securities fraud, failure to disclose regulatory risks, and a Chinese antitrust investigation. The stock experienced a significant 19% decline following the disclosure of the antitrust probe, indicating serious legal and regulatory challenges that pose material risks to investors.
The company faces a securities fraud class action lawsuit alleging material misstatements regarding monopolistic business activities and regulatory risks. Additionally, a Chinese antitrust investigation was revealed, resulting in a 17.05% stock price decline. These factors indicate significant legal and regulatory challenges.
The company faces securities fraud allegations for understating regulatory risks, a Chinese antitrust investigation was announced, and the stock experienced a significant 19% decline following the news disclosure. These factors indicate substantial legal and financial headwinds.
The company faces a securities class action lawsuit for allegedly understating regulatory risks. China initiated an antitrust investigation into TCOM's monopolistic business practices, resulting in significant stock price declines of 17.05% and 2.35% on consecutive days. These developments indicate serious legal and regulatory challenges.
The company is the subject of a securities class action lawsuit alleging material misstatements and omissions regarding regulatory risks from monopolistic business activities, resulting in investor damages.
The company faces a securities fraud class action lawsuit for allegedly concealing regulatory risks from monopolistic business activities. Additionally, China's antitrust probe and significant stock price decline (17.05%) following the disclosure of the investigation indicate serious legal and operational challenges.
The company faces a regulatory investigation by Chinese authorities regarding anti-monopoly law violations, resulting in an 18% intraday stock price decline and triggering a securities fraud investigation by a law firm on behalf of investors.
The company is under investigation by Chinese market regulators for potential antitrust violations, resulting in a 17% stock price decline. Allegations of materially misleading business information have prompted a securities class action lawsuit, indicating significant legal and financial risks for shareholders.
Articles that tag TCOM but are mainly about other companies.
Company is subject to a securities class action lawsuit with an important deadline mentioned, indicating alleged securities violations and investor harm.
Company faces securities fraud class action lawsuit with investors having losses exceeding $100,000, indicating material misstatements or omissions that harmed shareholders.
Class action lawsuit has been filed against the company with upcoming deadlines, indicating investor losses and potential legal violations.
Company is subject to securities class action lawsuit with an upcoming May 11 deadline, indicating alleged securities violations and investor harm.
Company is subject to a securities class action lawsuit filed by Rosen Law Firm, indicating allegations of securities fraud or misrepresentation to investors.
Company is subject to a securities class action lawsuit first filed by Rosen Law Firm, indicating alleged investor harm from company actions or disclosures.
Company is defendant in securities class action lawsuit filed by Rosen Law Firm, indicating alleged securities violations and investor losses.
Company is subject to a securities fraud class action related to an antitrust probe with a 19% stock decline, indicating material non-disclosure of regulatory risks.
Company faced a 19% stock decline following an antitrust probe, suggesting inadequate disclosure of regulatory risks and competitive challenges.
Company faced a 19% stock decline following an antitrust probe, resulting in a securities fraud class action lawsuit.
Company stock declined 19% following an antitrust probe, leading to a securities fraud class action lawsuit alleging failure to disclose material information.
Company is subject to a securities fraud class action lawsuit covering an extended period from April 2024 to January 2026, suggesting significant alleged misconduct.
Company is defendant in a securities class action lawsuit first filed by Rosen Law Firm, suggesting alleged material misstatements or disclosure failures to investors.
Articles and sentiment ratings from Massive / Polygon. Sentiment is the provider's model rating for this company, not Gainbot's view.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology
